81 results
Page 2 of 5
20-F/A
voqyfq
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.5
40ng diyw9b9
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
5cl38luw9mwov
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
kl7 21ceje
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
7ctu2ax9pb9
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
zyt ftkfvw6i
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
pscgxy
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.2
ojzbvgvec 9uwiycj12
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
nlhwnva6
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
9d54f2h0p8v4
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
pca 0fe2cfhb5kw4h1
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
k7ei jyc0
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
spvcgbwm7
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
huuhp53qmwa fceq
22 Jan 19
Current report (foreign)
4:43pm
6-K
EX-99.2
an2cx3nfpnh
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
191ngodnmcnd1y arx
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
nmu6acq sh5wj3z73
12 Jan 18
Annual report (foreign) (amended)
12:00am